UrofollitropinThird Party Manufacturing in India

Urofollitropin is a purified form of follicle-stimulating hormone (FSH) that works by mimicking the natural FSH produced by the pituitary gland. It binds directly to FSH receptors located on the surface of ovarian granulosa cells in women. This binding activates a signaling cascade inside the cells that triggers the growth and maturation of ovarian follicles, each of which contains an egg. The hormone stimulates the development of multiple follicles, a process essential for both natural ovulation and assisted reproductive technologies like in-vitro fertilization (IVF). Unlike earlier fertility treatments that contained a mix of hormones, urofollitropin is highly purified to contain mostly FSH with very little luteinizing hormone (LH) activity. This makes it particularly useful for women with polycystic ovary syndrome (PCOS) who already have high LH levels. The drug also stimulates the production of estradiol, a form of estrogen that prepares the uterine lining for implantation. By carefully controlling the dosage, doctors can stimulate the ovaries to produce the right number of mature eggs while minimizing the risk of overstimulation. The effect is dose-dependent and is monitored through ultrasound and blood hormone levels throughout the treatment cycle.

Therapeutic Uses

Urofollitropin is prescribed for the treatment of:

• Ovulation Induction in Anovulatory Women: Used to stimulate egg development in women who do not ovulate naturally, particularly those with polycystic ovary syndrome (PCOS) who have not responded to clomiphene therapy.
• Controlled Ovarian Hyperstimulation for ART: An essential component of in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) protocols to produce multiple mature follicles for egg retrieval.
• Assisted Reproductive Technology (ART): Used in conjunction with gonadotropin-releasing hormone (GnRH) agonists or antagonists and human chorionic gonadotropin (hCG) for timed ovulation and follicle harvesting.
• Gamete Intrafallopian Transfer (GIFT): Helps develop multiple follicles for gamete transfer procedures.

Why Manufacturers Choose Urofollitropin

Urofollitropin is a critical fertility drug with expanding demand across India and export markets. As a urine-derived biological product, it requires sophisticated extraction and purification technology that few Indian manufacturers possess. The growing infertility treatment market in India, driven by rising awareness and delayed childbearing, has created strong sustained demand for high-quality gonadotropins. Urofollitropin is available in 75 IU and 150 IU strengths as a lyophilized powder for injection, making it suitable for both domestic pharmaceutical marketing and export to regulated markets. Indian manufacturers with WHO-GMP certified facilities for biological products are well-positioned to meet this demand, particularly for third-party manufacturing and PCD franchise operations.

This makes Urofollitropin one of the most sought-after molecules for third party manufacturing in India, with consistent demand from fertility clinics and franchise operators.